Clinical Trial Update: Timolol Option for Ulcerated Hemangiomas (TOUCH Trial) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating timolol for ulcerated infantile hemangiomas (TOUCH Trial) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Hemangiomas

Drugs mentioned

• Timolol (timolol)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Infantile Hemangiomas | Phase 2 | Status: WITHDRAWN